Video: Who Am I?| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: environment

The ACR Is Instituting a New Governance Structure

David R. Karp, MD, PhD  |  February 10, 2022

In The Will to Govern Well, Glenn Tecker and co‐authors suggest that for associations, the term “governance” refers to “the decision‐making units of the organization and [the] relative powers, authorities, and responsibilities that each possesses, as well as … the composition of each unit and how individuals are selected to participate in each.” In 2019,…

Filed under:From the College Tagged with:ACR Board of DirectorsACR Committee on Nominations and Appointments

‘Nothing but NET[osis]’: RheumMadness 2022 Anti-NET Antibodies Scouting Report

The UNC Rheumatology Fellowship Program: Leah Bettner, MD; Shruti Chandramouli, MD; Christopher Overton, MD; Astia Allenzara, MD; Michael Cunningham, MD; & Luis Palomino, MD  |  February 8, 2022

Neutrophil extracellular traps (NETs) contribute to the pathogenesis of multiple autoimmune diseases. And research has shown that patients with antiphospholipid syndrome (APS) have higher levels of circulating anti-NET antibodies than healthy controls, indicating a potential biomarker.

Filed under:ConditionsOther Rheumatic ConditionsResearch Rheum Tagged with:anti-NET antibodiesAntiphospholipid Antibody Syndrome (APS)APScellsNETosisneutrophil extracellular trapsRheumMadness

Broadcasting Rheumatology Information to Wider Audiences

Kelly Tyrrell  |  February 3, 2022

Since starting the ACR on Air podcast in 2019, Mohammad Ursani, MD, FACP, RhMSUS, has become chair of the Committee on Communications and Marketing. Here, he shares some plans for the ACR website, podcast and more.

Filed under:American College of RheumatologyProfiles Tagged with:ACR Communications and Marketing CommitteeACR on Air podcastMohammad Ursani

Late 2021’s Awards, Appointments & Announcements in Rheumatology

Gretchen Henkel  |  January 10, 2022

Joan Von Feldt, MD, Named a PANLAR Master On Aug. 12, 2021, the Pan American League of Associations for Rheumatology (PANLAR) named Joan Von Feldt, MD, MSEd, FACR, FACP, MACR, a PANLAR Master. Dr. Von Feldt, a past president of the ACR (2015–16) and an emeritus professor of medicine at the Perelman School of Medicine,…

Filed under:Awards Tagged with:Dr. Joan Von FeldtDr. Lisa A. Zickuhr

Gorodenkoff / shutterstock.com

The NIAMS Diversity Supplement Program Offers Researcher Funding

Samantha C. Shapiro, MD  |  January 10, 2022

The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) is a component of the National Institutes of Health (NIH) that supports research into the causes, treatment and prevention of arthritis and musculoskeletal and skin diseases, as well as the training of basic and clinical scientists to carry out this research. NIAMS recognizes the…

Filed under:Career DevelopmentProfessional Topics Tagged with:National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)NIH research fundingResearch Funding

State Legislative Issues to Watch in 2022

Joseph Cantrell, JD  |  January 7, 2022

States increasingly take the lead on issues critical to our members and the field of rheumatology, including copay accumulator bans, white bagging restrictions, prior authorization and drug pricing.

Filed under:Legislation & Advocacy Tagged with:copay accumulatorsLegislation & Advocacypharmacy benefit managers (PBMs)prior authorizationstate legislationwhite bagging

Tocilizumab Promising for the Treatment of Polymyalgia Rheumatica

Michele B. Kaufman, PharmD, BCGP  |  January 1, 2022

In a study, patients with new-onset polymyalgia rheumatica (PMR) who were treated with subcutaneous tocilizumab were more likely to achieve sustained, glucocorticoid-free remission than patients who received placebo.

Filed under:ACR ConvergenceDrug UpdatesMeeting Reports

The 2021 ACR Awards of Distinction & Distinguished Fellows

Patrice Fusillo  |  December 16, 2021

During ACR Convergence 2021 in early November, the ACR honored a group of individuals who have made significant contributions to rheumatology research, education and patient care, announcing the recipients of the ACR’s 2021 Awards of Distinction, as well as the group of Distinguished Fellows. recognized for their contributions. Three pediatric rheumatologists and one pediatric fellow…

Filed under:AwardsProfessional Topics Tagged with:Dr. Alfredo AguirreDr. Alisa A. MuellerDr. Amanda E. NelsonDr. Anne R. BassDr. Brian M. FeldmanDr. Bryce A. BinstadtDr. Ida Dzifa DeyDr. Jacqueline MadisonDr. Jose U. ScherDr. Madelaine “Mattie” FeldmanDr. Mariana J. KaplanDr. Maximilian F. KonigDr. Michael H. WeismanDr. Naomi J. PatelDr. Philip SeoDr. Richard K. VeheDr. Rochelle L. CastilloDr. Roseanne F. ZhaoDr. Seoyoung C. KimDr. Sokratis ApostolidisDr. Stanley B. Cohen

The Transformative Power of Tragedy

Philip Seo, MD, MHS  |  December 16, 2021

On Sept. 11, 2001, I was at work. I had accepted a position as an assistant chief of service (ACS) for the Department of Medicine, which is Hopkins-speak for a hybrid position that involves all the administrative duties of a chief resident, plus the responsibility of an attending. For a year, I admitted patients to…

Filed under:OpinionRheuminationsSpeak Out Rheum Tagged with:COVID-19

Therapeutics for COVID-19: An update from ACR Convergence 2021

Lara C. Pullen, PhD  |  December 10, 2021

ACR CONVERGENCE 2021—Rheumatology patients who test positive for COVID-19 would benefit from early use of monoclonal antibodies, said Luis Ostrosky-Zeichner, MD, chief of the Division of Infectious Diseases, McGovern Medical School, University of Texas Health Science Center (UTHealth), Houston, in a session about effective treatment options for COVID-19. Acknowledging that the SARS-CoV-2 virus has already…

Filed under:ACR ConvergenceBiologics/DMARDsMeeting Reports Tagged with:ACR Convergence 2021COVID-19

  • « Previous Page
  • 1
  • …
  • 15
  • 16
  • 17
  • 18
  • 19
  • …
  • 102
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences